1
|
Skouvig Pedersen O, Sperling S, Koch A, Lillebaek T, Dahl VN, Fløe A. Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values. Clin Microbiol Infect 2025:S1198-743X(25)00003-5. [PMID: 39793964 DOI: 10.1016/j.cmi.2025.01.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2024] [Revised: 12/29/2024] [Accepted: 01/04/2025] [Indexed: 01/13/2025]
Abstract
OBJECTIVES The study aimed to investigate the association between quantitative T-SPOT.TB values and the risk of incident and prevalent tuberculosis disease (TBD), identify risk factors, and evaluate test accuracy. METHODS This retrospective cohort study followed patients tested consecutively with T-SPOT.TB at Aarhus University Hospital from 2010 to 2017, with follow-up for incident TBD through 2022. Data on demographics, comorbidities, medications, and TB status were collected from patient records and national registries. Cox proportional hazard models with restricted cubic splines assessed the risk of incident TBD (occurring ≥3 months post-test) by quantitative spot counts. Cox and log-binomial regressions identified risk factors for incident and prevalent TBD (occurring between 3 months before and after the test). Sensitivity, specificity, and predictive values assessed test accuracy. T-SPOT.TB was the index test, and microbiologically and/or clinically confirmed TBD was the reference standard. RESULTS Among 8542 individuals with complete follow-up, 59 developed incident TBD over 67 456 person-years. Among 9014 individuals tested once, 162 had prevalent TBD at the time of testing. The risk of incident TBD increased with higher spot counts, plateauing for tests with more than ten spots. The strongest risk factors for both incident and prevalent TBD were categorical T-SPOT.TB results: compared with negative tests (≤4 spots), adjusted hazard ratios for incident TBD were 5.0 (95% CI: 1.9-13.1) for borderline (5-7 spots) and 8.0 (95% CI: 4.0-15.7) for positive tests (≥8 spots). Adjusted risk ratios for prevalent TBD were 14.9 (95% CI: 7.7-28.9) for borderline and 35.6 (95% CI: 21.4-59.2) for positive tests. Sensitivities for incident and prevalent TBD were 54.0% (95% CI: 39.3-68.2%) and 78.4% (95% CI: 71.3-84.5%), respectively. Specificities were 84.8 (84.0-85.4) and 83.7 (82.9-84.4), respectively. DISCUSSION Incident TBD risk increases with T-SPOT.TB values but plateaus beyond 10 spots. Borderline and positive T-SPOT.TB results are strongly linked to TBD risk.
Collapse
Affiliation(s)
- Ole Skouvig Pedersen
- Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
| | - Søren Sperling
- Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark; Department of Respiratory Diseases, Gødstrup Hospital, Gødstrup, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
| | - Anders Koch
- Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
| | - Troels Lillebaek
- Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, Denmark; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark
| | - Victor Naestholt Dahl
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
| | - Andreas Fløe
- Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
| |
Collapse
|
2
|
Nordholm AC, Andersen AB, Wejse C, Norman A, Ekstrøm CT, Andersen PH, Koch A, Lillebaek T. Mental illness, substance abuse, and tuberculosis risk. J Infect 2023; 86:e135-e137. [PMID: 36716977 DOI: 10.1016/j.jinf.2023.01.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 01/06/2023] [Accepted: 01/21/2023] [Indexed: 01/30/2023]
Affiliation(s)
- Anne Christine Nordholm
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, 5 Artillerivej, Copenhagen S 2300, Denmark.
| | - Aase Bengaard Andersen
- Department of Infectious Diseases, Rigshospitalet Copenhagen University Hospital, 9 Blegdamsvej, Copenhagen Ø 2100, Denmark
| | - Christian Wejse
- Department of Infectious Diseases, Aarhus University Hospital, 99 Palle Juul-Jensens Boulevard, Aarhus N 8200, Denmark; Center for Global Health, Aarhus University, 2 Bartholins Allé, Aarhus C 8000, Denmark
| | - Anders Norman
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, 5 Artillerivej, Copenhagen S 2300, Denmark
| | - Claus Thorn Ekstrøm
- Section of Biostatistics, Department of Public Health, University of Copenhagen, 5 Øster Farimagsgade, Copenhagen K 1353, Denmark
| | - Peter Henrik Andersen
- Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej, Copenhagen S 2300, Denmark
| | - Anders Koch
- Department of Infectious Diseases, Rigshospitalet Copenhagen University Hospital, 9 Blegdamsvej, Copenhagen Ø 2100, Denmark; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej, Copenhagen S 2300, Denmark; Global Health Section, Department of Public Health, University of Copenhagen, 5 Øster Farimagsgade, Copenhagen K 1353, Denmark
| | - Troels Lillebaek
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, 5 Artillerivej, Copenhagen S 2300, Denmark; Global Health Section, Department of Public Health, University of Copenhagen, 5 Øster Farimagsgade, Copenhagen K 1353, Denmark
| |
Collapse
|
3
|
Stærke NB, Martinsen JT, Jensen TT, Weinreich UM, Hilberg O, Folkvardsen DB, Wejse C, Fløe A. A cohort study of the long-term outcome of latent tuberculosis infection among socially marginalized people in a low-incidence country. Int J Infect Dis 2022; 124 Suppl 1:S56-S62. [PMID: 35231610 DOI: 10.1016/j.ijid.2022.02.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 02/14/2022] [Accepted: 02/15/2022] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Tuberculosis (TB) prevalence is high among socially marginalized citizens in Denmark, and management of latent TB infection (LTBI) may be part of preventing new cases. Patients with LTBI are offered either preventive treatment (TPT) or follow-up chest x-rays, but knowledge about the long-term outcome in terms of active TB is sparse. METHODS We performed a retrospective cohort study investigating the long-term outcomes for socially marginalized citizens who were diagnosed with LTBI or who had a positive interferon-gamma release assay (IGRA) but were lost to follow-up. Information on TB examinations, diagnostics, and treatment along with data on death were gathered from medical records from the date of positive IGRA to February 1, 2021. RESULTS We identified 119 patients with LTBI, 18 of which (15.1%) were diagnosed with TB during the follow-up period (mean, 4.5 years). TPT was completed by 36.1% and the TB incidence rate ratio of those completing TPT to those who did not was 0.78 (confidence interval, 0.25-2.17; P =.6). Of the patients with TB, 16 of 18 achieved treatment success. CONCLUSION High rates of TB development are found among socially marginalized citizens with LTBI. Overall incidence of TB was not significantly reduced by administration of TPT, although TB did not develop in the first 2 years following TPT.
Collapse
Affiliation(s)
- Nina Breinholt Stærke
- Department of Infectious Diseases, Aarhus University Hospital, Palle-Juul Jensens Boulevard 99, 8200, Aarhus N., Denmark; Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200, Aarhus N, Denmark
| | - Janne Tegder Martinsen
- Department of Pulmonary Medicine, Sydvestjysk Sygehus, Finsensgade 35, 6700, Esbjerg, Denmark
| | - Torben Tranborg Jensen
- Department of Pulmonary Medicine, Sydvestjysk Sygehus, Finsensgade 35, 6700, Esbjerg, Denmark
| | - Ulla Møller Weinreich
- Department of Respiratory Diseases, Aalborg University Hospital, Mølleparkvej 4, 9000, Aalborg, Denmark; The Clinical Institute, Aalborg University, Søndre Skovvej 15, 9000, Aalborg, Denmark
| | - Ole Hilberg
- Department of Internal Medicine, Sygehus Lillebælt, Beriderbakken 4, 7100, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, J.B. Winsløws Vej 19, 3., 5000, Odense C, Denmark
| | - Dorte Bek Folkvardsen
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Artillerivej 5, 2300, Copenhagen, Denmark
| | - Christian Wejse
- Department of Infectious Diseases, Aarhus University Hospital, Palle-Juul Jensens Boulevard 99, 8200, Aarhus N., Denmark; GloHAU, Center for Global Health, Department of Public Health, Aarhus University, Bartholins allé 2, 8000, Aarhus C, Denmark
| | - Andreas Fløe
- Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark
| |
Collapse
|
4
|
Nordholm AC, Andersen AB, Wejse C, Norman A, Ekstrøm CT, Andersen PH, Koch A, Lillebaek T. Social determinants of tuberculosis: a nationwide case-control study, Denmark, 1990-2018. Int J Epidemiol 2022; 51:1446-1456. [PMID: 35595514 DOI: 10.1093/ije/dyac109] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2022] [Accepted: 05/05/2022] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND The global vision is a world free of tuberculosis (TB). Even in resource-rich TB low-incidence settings, we need more focus on the role of social risk factors to end the TB epidemic. METHODS Nationwide, retrospective register-based, case-control study from 1990 to 2018, including all TB patients in Denmark ≥18 years old (n = 9581) matched 1:3 on sex and age with population controls. TB risk factors were assessed in logistic regression models and estimated by odds ratio (OR). RESULTS All TB patients had considerably lower socio-economic status compared with controls (P < 0.0001). Among ethnic Danes, TB was mostly found among males, persons between 35 and 65 years, those living alone, those with low educational level, persons on social welfare benefits and those with low income. Conversely, for migrants, being younger, sex and living alone were less important, whereas having children was protective. In an adjusted multivariable regression model among Danes, key risk factors for TB were being on disability pension (OR = 2.7) and cash benefits (OR = 4.7). For migrants, fewer social risk factors increased TB risk, although low income and cash benefits did (OR = 3.1). CONCLUSION Even today in a resourceful setting, socio-economic status drives disparities in health. In our study, multifactorial social deprivation was highly associated with TB. Especially household structure, education, employment and income were important risk factors that should be addressed in the future to accelerate TB control and end the TB epidemic.
Collapse
Affiliation(s)
- Anne Christine Nordholm
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark
| | - Aase Bengaard Andersen
- Department of Infectious Diseases, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
| | - Christian Wejse
- Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.,Department of Public Health, Center for Global Health, Aarhus University, Aarhus, Denmark
| | - Anders Norman
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark
| | - Claus Thorn Ekstrøm
- Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Peter Henrik Andersen
- Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
| | - Anders Koch
- Department of Infectious Diseases, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.,Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.,Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Troels Lillebaek
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.,Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|